SCHEMBL1111686

SCHEMBL1111686

COc1nccnc1C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.47
TSHR P16473 2/20 0.47
KDM4E B2RXH2 10/20 0.42
ALDH1A1 P00352 3/20 0.41
ALOX15 P16050 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
CYP3A4 P08684 1/20 0.41
BLM P54132 1/20 0.41
AGER Q15109 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
TDP1 Q9NUW8 2/20 0.40
POLB P06746 1/20 0.40
ASPH Q12797 2/20 0.38
KDM8 Q8N371 2/20 0.38
MYC P01106 1/20 0.37
KMT2A Q03164 1/20 0.37
KMO O15229 1/20 0.36
CYP1A2 P05177 1/20 0.36
SLC13A5 Q86YT5 1/20 0.35
CA1 P00915 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30592770 1.00 MAPT (0.47) MAPTTSHRKDM4EALDH1A1ALOX15
Hydrochloric Acid SCHEMBL17674838 0.98 MAPT (0.46) MAPTTSHRKDM4EALDH1A1ALOX15
SCHEMBL336307 0.83 BCHE (0.39) MAPTTSHRKDM4EALDH1A1L3MBTL1
SCHEMBL30496336 0.81 CDC7 (0.46) MAPTTSHRKDM4EALDH1A1POLB
SCHEMBL2215923 0.81 CDC7 (0.46) MAPTTSHRKDM4EALDH1A1POLB
SCHEMBL17674836 0.81 MAPT (0.36) MAPTTSHRKDM4EL3MBTL1TDP1
SCHEMBL31214279 0.81 NPSR1 (0.48) MAPTTSHRKDM4EALDH1A1L3MBTL1
SCHEMBL958881 0.81 NPSR1 (0.48) MAPTTSHRKDM4EALDH1A1L3MBTL1
SCHEMBL991266 0.79 KDM4E (0.45) MAPTTSHRKDM4EALDH1A1ALOX15
SCHEMBL7573300 0.78 MAPT (0.41) MAPTTSHRKDM4EALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102414190-B Inhibitors of NF-kB PROFECTUS BIOSCIENCES INC 2015-06-03 CN claimed
EP-2411376-B1 INHIBITORS OF NF-KB PROFECTUS BIOSCIENCES INC (US) 2015-04-22 EP claimed
US-8629164-B2 Inhibitors of NF-κB PROFECTUS BIOSCIENCES, INC. (US) 2014-01-14 US claimed
EP-2456763-A1 OXAZINE DERIVATIVES AND THEIR USE AS BACE INHIBITORS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS Novartis AG (CH) 2012-05-30 EP claimed
EP-3710428-B1 MODULATORS OF THE INTEGRATED STRESS PATHWAY CALICO LIFE SCIENCES LLC (US) 2026-03-25 EP disclosed
US-20240307382-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY ABBVIE INC. 2024-09-19 US disclosed
WO-2024140431-A1 COMPOUNDS COMPRISING HETEROARYL RINGS AND COMPOSITIONS AND METHODS THEREOF IONGEN THERAPEUTICS CO., LTD. (CN) 2024-07-04 WO disclosed
CN-112204009-B Modulators of integrated stress pathways 卡里科生命科学有限责任公司 2024-05-07 CN disclosed
CN-109956929-B Heterocyclic derivative, preparation method, pharmaceutical composition and application thereof 上海迪诺医药科技有限公司 2023-09-19 CN disclosed
EP-3452456-B1 BICYCLIC MODULATORS OF THE INTEGRATED STRESS PATHWAY CALICO LIFE SCIENCES LLC (US) 2023-07-05 EP disclosed
EP-3600312-B1 PIPERIDINYL- AND PIPERAZINYL-SUBSTITUTED HETEROAROMATIC CARBOXAMIDES AS MODULATORS OF GPR6 TAKEDA PHARMACEUTICALS CO (JP) 2023-05-17 EP disclosed
CN-110520127-B Piperidinyl-substituted and piperazinyl-substituted heteroaromatic carboxamides as modulators of GPR6 武田药品工业株式会社 2023-05-16 CN disclosed
WO-2010111460-A1 INHIBITORS OF NF-KB PROFECTUS BIOSCIENCES, INC. (US) 2010-09-30 WO disclosed
WO-2009127679-A1 INDOLES AS MODULATORS OF NICOTICIC ACETYLCHOLINE RECEPTOR SUBTYPE ALPHA-7 GLAXO GROUP LIMITED (GB) 2009-10-22 WO disclosed
US-20080064708-A1 Substituted Pyrazinecarboxylic Acid Anilde Dervatives Or Salts Thereof, Intermediates Of The Same, Pesticides for Agricultural And Horticultural Use, and Usage Thereof NIHON NOHYAKU CO., LTD. (JP) 2008-03-13 US disclosed
CN-1956970-A Substituted pyrazinecarboxylic acid anilide derivative or salt thereof, intermediate thereof, agricultural/horticultural agent and use thereof NIHON NOHYAKU CO LTD (JP) 2007-05-02 CN disclosed
EP-1757595-A1 SUBSTITUTED PYRAZINECARBOXYLIC ACID ANILIDE DERIVATIVES OR SALTS THEREOF, INTERMEDIATES OF THE SAME, PESTICIDES FOR AGRICULTURAL AND HORTICULTURAL USE, AND USAGE THEREOF Nihon Nohyaku Co., Ltd. (JP) 2007-02-28 EP disclosed
US-20050171350-A1 Benzhydryl derivatives FUJISAWA PHARAMACEUTICAL CO., LTD. (JP) 2005-08-04 US disclosed
EP-1456201-A1 BENZHYDRYL DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-09-15 EP disclosed
WO-2003053957-A1 BENZHYDRYL DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (US) 2003-07-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080064708-A1 Substituted Pyrazinecarboxylic Acid Anilde Dervatives Or Salts Thereof, Intermediates Of The Same, Pesticides for Agricultural And Horticultural Use, and Usage Thereof ATIC, HDHD5, AGPS MAPT 4593/4885TSHR 640/4885KDM4E 1393/4885
US-20240307382-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY ATF4, ATF1, DDIT3 MAPT 3293/4885TSHR 3921/4885KDM4E 4646/4885
US-20050171350-A1 Benzhydryl derivatives BDKRB1, BDKRB2, TACR1 MAPT 3238/4885TSHR 151/4885KDM4E 3170/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.